Cleared Traditional

K841302 - DIAGNON FOLATE 125I RIA KIT

K841302 is the FDA 510(k) clearance for DIAGNON FOLATE 125I RIA KIT by Diagnon Corp.. It is a Class 2 Chemistry device (product code CGN) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1984
Decision
84d
Days
Class 2
Risk

K841302 is an FDA 510(k) clearance for the DIAGNON FOLATE 125I RIA KIT. Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Diagnon Corp. (Mchenry, US). The FDA issued a Cleared decision on June 22, 1984 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1295 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnon Corp. devices

Submission Details

510(k) Number K841302 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1984
Decision Date June 22, 1984
Days to Decision 84 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 88d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 52
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K841302.
MILENIA FOLIC ACID
K921614 · Diagnostic Products Corp. · Jun 1992
CEDIA RED BLOOD CELL FOLATE REAGENT PACK
K921689 · Microgenics Corp. · Jun 1992
CIBA CORNING MAGIC LITE FOLATE IMMUNOASSAY
K893684 · Ciba Corning Diagnostics Corp. · Jul 1989
SOLID PHASE SIMUL TRAC VITAMIN B12
K822728 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Nov 1982
VITAMIN B12/FOLATE DUAL RADIOASSAY KITS
K812979 · Amersham Corp. · Nov 1981
QUANTA PHASE VITAMIN B-12/FOLATE RAD
K811177 · Bio-Rad · May 1981